🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of samurac...
Status
Completed
Location
Ocala Oncology Center PL DBA Florida Cancer Affiliates
Start Date
2023-11-16
Trial ID
NCT05963984
Treatments Being Tested
Breast cancer is one of the most common cancers in women. 20-30 % of all br...
Status
Completed
Location
Klinikum rechts der Isar der TU München, Klinik und Poliklinik für Frauenheilkunde
Start Date
2020-12-22
Trial ID
NCT04681768
Treatments Being Tested
The purpose of this study is to determine whether IMC-A12 offers increased ...
Status
Completed
Location
ImClone Investigational Site
Start Date
2008-08
Trial ID
NCT00728949
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability and phar...
Status
Completed
Location
ATTN-Research Pharmacist
Start Date
2012-04-30
Trial ID
NCT01597193
Treatments Being Tested
The subjects in this trial have been diagnosed as having a pre-cancerous di...
Status
Terminated
Location
Norris Comprehensive Cancer Center
Start Date
2006-08
Trial ID
NCT00183963
Treatments Being Tested
This is a single arm, multicentric phase II study of milademetan plus fulve...
Status
Terminated
Location
Centre Leon Berard
Start Date
2023-10-12
Trial ID
NCT05932667
Treatments Being Tested
This is a phase 2, open-label, singled-arm clinical trial determining effic...
Status
Recruiting
Location
Chao Family Comprehensive Cancer Center, University of California, Irvine
Start Date
2022-08-31
Trial ID
NCT05524584
Treatments Being Tested
This study was planned as a prospective multicenter NIS. This study was obs...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-07-27
Trial ID
NCT04943497
Treatments Being Tested
This is an open-label, multicentre, 4-arm randomised phase II trial of fulv...
Status
Completed
Location
ICO Paul Papin
Start Date
2014-01-16
Trial ID
NCT02216786
Treatments Being Tested
The purpose of the study is to test a treatment strategy with currently app...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2024-08-14
Trial ID
NCT06409390